ENVB — ENVERIC BIOSCIENCES INC
As of Q2 2026, 7 SEC-registered investment managers reported holding ENVB (ENVERIC BIOSCIENCES INC) in their latest 13F filings, with a combined reported value of $94.95K across 68.80K shares. That is +92.1% by share count (+32.99K shares) versus the previous quarter, while reported value moved +36.7%. Ownership is concentrated: the five largest holders account for 99.9% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 2 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ENVB is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Goldman Sachs Group history | Q4 2021 | 58.91K | $55.00K | 0.00% | New |
| Millennium Management history | Q2 2022 | 227.62K | $49.00K | 0.00% | New |
| Renaissance Technologies history | Q2 2026 | 32.06K | $44.24K | 0.00% | New |
| T. Rowe Price Associates history | Q1 2022 | 107.50K | $35.00K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 13.96K | $19.27K | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 11.79K | $16.27K | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 10.73K | $14.81K | 0.00% | New |
| Citigroup Inc history | Q4 2025 | 2.28K | $8.26K | 0.00% | New |
| Northern Trust Corp history | Q2 2022 | 36.50K | $8.00K | 0.00% | Hold |
| Vanguard Group history | Q4 2024 | 18.20K | $6.51K | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q1 2025 | 3.43K | $4.76K | 0.00% | New |
| Two Sigma Investments history | Q4 2024 | 12.14K | $4.35K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q1 2022 | 11.42K | $4.00K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 201 | $277 | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 51 | $70 | 0.00% | Hold |
| Bank of America Corp history | Q4 2025 | 5 | $18 | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 1 | $1 | 0.00% | Hold |
New Positions (Q2 2026)
- Renaissance Technologies 32.06K sh · $44.24K
- Citadel Advisors 13.96K sh · $19.27K
- Morgan Stanley 10.73K sh · $14.81K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 17 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies | 492.55K | 554.10K | 1.99M | 1.09M | — | — | — | 17.17K | — | — | — | — | — | — | — | 37.01K | — | — | — | 32.06K |
| Citadel Advisors | 400.25K | 517.04K | 304.23K | 36.20K | — | — | — | 13.93K | — | — | 40.10K | — | 12.75K | 15.02K | 20.06K | — | 22.67K | — | — | 13.96K |
| Geode Capital Management | 115.26K | 166.54K | 166.54K | 204.57K | — | — | — | — | 13.12K | 13.12K | 13.12K | 44.66K | 217.89K | 216.59K | 26.56K | 28.16K | 28.51K | — | 32.15K | 11.79K |
| Morgan Stanley | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | — | — | — | — | 13.02K | — | — | — | 10.73K |
| UBS Group AG | 477 | 13.97K | 97.90K | 477 | 5.20K | 2.41K | 5.32K | 54 | 311 | 10 | 4.98K | 43.56K | 731 | 78.41K | 42.76K | 27.34K | 105.33K | 2.90K | 3.61K | 201 |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 9.01K | 9.01K | 601 | 601 | 601 | 51 | 51 | 51 |
| Wells Fargo & Co | 904 | 904 | 972 | 1.12K | 27 | 29 | 29 | 30 | 34 | 33 | 37 | 16 | 16 | 16 | 2 | 2 | 2 | 1 | 1 | 1 |
| Bank of America Corp | — | — | — | — | 100 | 100 | 100 | 101 | 100 | 100 | 100 | 164 | 173 | 180 | — | 24 | 26 | 5 | — | — |
| Citigroup Inc | — | — | 16.77K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.28K | — | — |
| Fidelity Management & Research (FMR) | — | — | — | 3 | 1 | — | — | — | — | — | — | 120 | — | — | 3.43K | — | — | — | — | — |
| JPMorgan Chase & Co | — | — | 11.42K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Goldman Sachs Group | — | 58.91K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Two Sigma Investments | 43.80K | 42.05K | — | — | — | — | — | — | — | — | 15.40K | — | 13.38K | 12.14K | — | — | — | — | — | — |
| Millennium Management | — | — | — | 227.62K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Northern Trust Corp | 36.50K | 36.50K | 36.50K | 36.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| T. Rowe Price Associates | 53.10K | 138.90K | 107.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | 495.65K | 760.59K | 760.59K | 760.59K | 14.43K | 14.43K | 12.12K | 12.52K | 18.02K | 18.20K | 18.20K | 18.20K | 18.20K | 18.20K | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details